Additional targeted studies using various models of neurodevelopmental disorders, such as ADHD, are required to clarify the broader therapeutic applicability and precise underlying mechanisms of Rg1. The gene discussed is PPP1R3A; the disease is attention deficit-hyperactivity disorder.